IMO-3100

N/A

Report date: 2022/07/04 19:38:02
NME

Base Information

Drug NameIMO-3100
Drug Alias NameIMO-3100
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide
Mechanisms of ActionToll like receptor 7 antagonistsToll like receptor 9 antagonists
TargetsToll like receptor 9Toll like receptor 7
Therapy Area/IndicationsPlaque psoriasis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesAceragen Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAceragen Inc
Active IndicationsN/A
Inactive IndicationsPlaque psoriasis

Other Information

ATC CodeN/A
Related LinksN/A